1.96BMarket Cap
LossP/E TTM
RAPP Financials
See Rapport Therapeutics Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.
Rapport Therapeutics Inc Earnings Date
Latest Release
May 7, 2026
EPS / Forecast
-0.42/-0.67
Revenue / Forecast
20.00M/8.57M
Analyst Rating
BUY
2026/08/02
FAQs
What are the current assets of Rapport Therapeutics Inc?
According to Rapport Therapeutics Inc's FY2025 earnings report, its current assets were 498.56M, with a year-on-year change of 60.93.
What are the total assets of Rapport Therapeutics Inc?
According to Rapport Therapeutics Inc's FY2025 earnings report, its total assets of Rapport Therapeutics Inc were 512.43M, with a year-on-year change of 62.71.
What are the total liabilities of Rapport Therapeutics Inc?
According to Rapport Therapeutics Inc's FY2025 earnings report, its total liabilities of Rapport Therapeutics Inc were 27.78M, with a year-on-year change of 192.22.
What is the total equity of Rapport Therapeutics Inc?
According to Rapport Therapeutics Inc's FY2025 earnings report, its total equity of Rapport Therapeutics Inc was 484.65M, with a year-on-year change of 58.68.
What is the net operating income of Rapport Therapeutics Inc?
According to Rapport Therapeutics Inc's FY2025 earnings report, its net operating income of Rapport Therapeutics Inc was -125.10M, with a year-on-year change of -50.62.
What is the net investment of Rapport Therapeutics Inc?
According to Rapport Therapeutics Inc's FY2025 earnings report, its net investment of Rapport Therapeutics Inc was -187.47M, with a year-on-year change of -10.19.
What is the net financing of Rapport Therapeutics Inc?
According to Rapport Therapeutics Inc's FY2025 earnings report, its net financing of Rapport Therapeutics Inc was 270.79M, with a year-on-year change of 22.18.
What is the Earnings Per Share (EPS) of Rapport Therapeutics Inc?
According to Rapport Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -2.86, with a year-on-year change of 24.17.
What is the net income of Rapport Therapeutics Inc?
According to Rapport Therapeutics Inc's FY2025 earnings report, its net income was -111.48M, with a year-on-year change of -42.37.
What is the Return on Equity (ROE) of Rapport Therapeutics Inc?
According to Rapport Therapeutics Inc's FY2025 earnings report, its Return on Equity (ROE) was -28.22, with a year-on-year change of 49.58.
What is the Return on Assets (ROA) of Rapport Therapeutics Inc?
According to Rapport Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was -26.95, with a year-on-year change of 19.06.
What is the operating profit of Rapport Therapeutics Inc?
According to Rapport Therapeutics Inc's FY2025 earnings report, its operating profit was -125.10M, with a year-on-year change of -50.62.